225 related articles for article (PubMed ID: 21498513)
1. Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.
Wegmann S; Schöler J; Bippes CA; Mandelkow E; Muller DJ
J Biol Chem; 2011 Jun; 286(23):20512-24. PubMed ID: 21498513
[TBL] [Abstract][Full Text] [Related]
2. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
Hochgräfe K; Sydow A; Mandelkow EM
FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
[TBL] [Abstract][Full Text] [Related]
3. Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity.
Kumar S; Tepper K; Kaniyappan S; Biernat J; Wegmann S; Mandelkow EM; Müller DJ; Mandelkow E
J Biol Chem; 2014 Jul; 289(29):20318-32. PubMed ID: 24825901
[TBL] [Abstract][Full Text] [Related]
4. Conformational diversity of wild-type Tau fibrils specified by templated conformation change.
Frost B; Ollesch J; Wille H; Diamond MI
J Biol Chem; 2009 Feb; 284(6):3546-51. PubMed ID: 19010781
[TBL] [Abstract][Full Text] [Related]
5. Trans-cellular propagation of Tau aggregation by fibrillar species.
Kfoury N; Holmes BB; Jiang H; Holtzman DM; Diamond MI
J Biol Chem; 2012 Jun; 287(23):19440-51. PubMed ID: 22461630
[TBL] [Abstract][Full Text] [Related]
6. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
7. Spreading of Tau Protein Does Not Depend on Aggregation Propensity.
Rodrigues S; Anglada-Huguet M; Hochgräfe K; Kaniyappan S; Wegmann S; Mandelkow EM
J Mol Neurosci; 2023 Oct; 73(9-10):693-712. PubMed ID: 37606769
[TBL] [Abstract][Full Text] [Related]
8. Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
Xia Y; Sorrentino ZA; Kim JD; Strang KH; Riffe CJ; Giasson BI
J Biol Chem; 2019 Nov; 294(48):18488-18503. PubMed ID: 31653695
[TBL] [Abstract][Full Text] [Related]
9. Anti-aggregant tau mutant promotes neurogenesis.
Joseph M; Anglada-Huguet M; Paesler K; Mandelkow E; Mandelkow EM
Mol Neurodegener; 2017 Dec; 12(1):88. PubMed ID: 29202785
[TBL] [Abstract][Full Text] [Related]
10. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
11. Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: A comparative study.
Jangholi A; Ashrafi-Kooshk MR; Arab SS; Riazi G; Mokhtari F; Poorebrahim M; Mahdiuni H; Kurganov BI; Moosavi-Movahedi AA; Khodarahmi R
Arch Biochem Biophys; 2016 Nov; 609():1-19. PubMed ID: 27638048
[TBL] [Abstract][Full Text] [Related]
12. Alternative conformations of the Tau repeat domain in complex with an engineered binding protein.
Grüning CSR; Mirecka EA; Klein AN; Mandelkow E; Willbold D; Marino SF; Stoldt M; Hoyer W
J Biol Chem; 2014 Aug; 289(33):23209-23218. PubMed ID: 24966331
[TBL] [Abstract][Full Text] [Related]
13. Using intramolecular disulfide bonds in tau protein to deduce structural features of aggregation-resistant conformations.
Walker S; Ullman O; Stultz CM
J Biol Chem; 2012 Mar; 287(12):9591-600. PubMed ID: 22291015
[TBL] [Abstract][Full Text] [Related]
14. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
[TBL] [Abstract][Full Text] [Related]
15. Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
Green C; Sydow A; Vogel S; Anglada-Huguet M; Wiedermann D; Mandelkow E; Mandelkow EM; Hoehn M
Mol Neurodegener; 2019 Mar; 14(1):13. PubMed ID: 30917861
[TBL] [Abstract][Full Text] [Related]
16. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations.
Dong X; Qi R; Qiao Q; Li X; Li F; Wan J; Zhang Q; Wei G
Phys Chem Chem Phys; 2021 Sep; 23(36):20406-20418. PubMed ID: 34494046
[TBL] [Abstract][Full Text] [Related]
17. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias.
Barghorn S; Zheng-Fischhöfer Q; Ackmann M; Biernat J; von Bergen M; Mandelkow EM; Mandelkow E
Biochemistry; 2000 Sep; 39(38):11714-21. PubMed ID: 10995239
[TBL] [Abstract][Full Text] [Related]
18. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.
Khlistunova I; Biernat J; Wang Y; Pickhardt M; von Bergen M; Gazova Z; Mandelkow E; Mandelkow EM
J Biol Chem; 2006 Jan; 281(2):1205-14. PubMed ID: 16246844
[TBL] [Abstract][Full Text] [Related]
19. Structural polymorphism of 441-residue tau at single residue resolution.
Mukrasch MD; Bibow S; Korukottu J; Jeganathan S; Biernat J; Griesinger C; Mandelkow E; Zweckstetter M
PLoS Biol; 2009 Feb; 7(2):e34. PubMed ID: 19226187
[TBL] [Abstract][Full Text] [Related]
20. Analysis of in vivo turnover of tau in a mouse model of tauopathy.
Yamada K; Patel TK; Hochgräfe K; Mahan TE; Jiang H; Stewart FR; Mandelkow EM; Holtzman DM
Mol Neurodegener; 2015 Oct; 10():55. PubMed ID: 26502977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
